(Health-NewsWire.Net, July 27, 2017 ) Publisher the industry analysis specialist has released its latest report "CountryFocus Healthcare Regulatory and Reimbursement Landscape-Brazil". The report is an essential source of information on analysis of the healthcare regulatory and reimbursement landscape in Brazil. It identifies the key trends in the country's healthcare market and provides insights into its demographic regulatory and reimbursement landscape and healthcare infrastructure. Most importantly the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases secondary research and in-house analysis by Publisher's team of industry experts.
Brazil's population grew from 191 million in 2009 to 202 million in 2016 mainly due to the increase in the life expectancy. The value of the pharmaceuticals market increased from $15.4 billion in 2009 to $25.3 billion in 2016 at a Compound Annual Growth Rate (CAGR) of 3.4% and this value is expected to increase further from $26.1 billion in 2017 to $29.9 billion in 2021 at a CAGR of 3.4%. The medical device market was worth $7.1 billion in 2009 and reached $9.7 billion in 2016. It is forecast to grow at a CAGR of 6.4% from $10.9 billion in 2017 to $14 billion in 2021.
These positive growth trends can be primarily attributed to- - An increasingly elderly population - Increased accessibility to healthcare professionals in remote areas.
Scope
The report provides information on the healthcare regulatory and reimbursement landscape in Brazil and includes- - An overview of the pharmaceutical and medical device markets comprising market size segmentation and key drivers and barriers - Profiles and SWOT analyses of the major players in the pharmaceutical market Pfizer Hypermarcas Roche Novartis and Sanofi and Profiles and SWOT analyses of the major players in the medical device market Johnson & Johnson B.Braun Medtronic Baxter and GSK. - An insightful review of the reimbursement and regulatory landscape with analysis covering details of the country's healthcare reimbursement process regulatory agencies and the approval processes for new drugs and medical devices - Detailed analysis of the country's political and economic environment covering economic indicators demographics healthcare infrastructure and healthcare expenditure - An overview of the opportunities for and challenges to growth in the Brazil healthcare market
This report will enhance your decision-making capability by allowing you to- - Develop business strategies by understanding the trends shaping and driving Brazil's healthcare market - Drive revenues by understanding the key trends reimbursement and regulatory policies pharmaceutical market segments and companies likely to impact Brazil's healthcare market in the future - Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors' performance - Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation investment and strategic partnership Table of Content 1.1 List of Tables 4 2 Executive Summary 8 3 Introduction 12 4 Overview of Pharmaceutical and Medical Device Markets 13 5 Market Access 99 6 Country Analysis 127 7 Opportunities and Challenges 181 Inquire for Report at http://www.reportsweb.com/inquiry&RW0001881608/buying